TABLE 3.
Non-randomized studies of normothermic machine perfusion for hearts from donation after brainstem death, without control group.
| Study | Number of patients | Total preservation time (min) | Outcomes | Publication type | Risk case |
|---|---|---|---|---|---|
| Ayan Mukash et al., 2019 (32) | 47 | Not reported | Kaplan-Meier survival estimates 91%, 85%, and 80% at 3 months, 6 months, and 1 year | Conference abstract | Yes |
| Garcia et al., 2016 (33) | 60 | Not reported | Survival rate similar between regular donor group (n = 24) and extended criteria donor group (n = 36) | Conference abstract | Yes |
| Garcia et al., 2014 (16) | 26 | 371 | Survival rate 100% at 1 month and 96% at follow-up of 257 days | Article | Yes |
| Kaliyev et al., 2019 (10) | 43 | 344 | 30-day survival 100% | Article | Not mentioned |
| Koerner et al., 2012 (34) | 13 | Not reported | 1- and 2-year survival rate 89% | Conference abstract | Not mentioned |
| Nurmykhametova et al., 2018 (5) | 1 | 960 | Total out-of-body time 16 h, longest out-body time to date | Conference abstract | Yes |
| Rojas et al., 2020 (40) | 76 | 382 | Survival rate 92.1% and 82.9% at 30 days and 1 year | Conference abstract | Yes |
| Stamp et al., 2015 (21) | 1 | 611 | Total out-of-body time 10 h | Article | Yes |
| Yeter et al., 2014 (35) | 21 | 388 | Freedom from cardiac-related death 95% at 30 days and 6 months, 87% at 1 and 4 years | Conference abstract | Yes |